AVKARE Inc. recalls Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828
Recalled November 8, 2017 · FDA recall D-0055-2018 · AVKARE
Hazard
Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid. · FDA Class II
Units
274 cartons
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
Product
Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.
Manufacturer(s)
AVKARE Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →